Integer Holdings (ITGR) Income from Non-Controlling Interests (2010 - 2018)
Integer Holdings (ITGR) posted Income from Non-Controlling Interests of $3.4 million for Q1 2018, up 563.23% sequentially from $514000.0 in Q4 2017, and up 94.8% YoY from $1.8 million in Q1 2017.
Integer Holdings (ITGR) Income from Non-Controlling Interests (2010 - 2018) Analysis & Trends
Integer Holdings has reported Income from Non-Controlling Interests for 9 years, with the latest figure at $3.4 million in Q1 2018.
- Quarterly Income from Non-Controlling Interests rose 94.8% year-over-year to $3.4 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $3.9 million (up 1.06% YoY) and the FY2018 annual result came in at $16000.0, down 99.29% from the prior year.
- Income from Non-Controlling Interests improved to $3.4 million in Q1 2018 per ITGR's latest filing, from $514000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $3.4 million in Q1 2018 and troughed at -$1.2 million in Q3 2016.
- A 5-year average of $483588.2 and a median of $86000.0 in 2014 frame the typical range for Income from Non-Controlling Interests.
- The widest YoY moves for Income from Non-Controlling Interests: up 46550.0% in 2016, down 1301.12% in 2016.
- Over 5 years, Income from Non-Controlling Interests stood at -$49000.0 in 2014, then jumped by 1506.12% to $689000.0 in 2015, then surged by 304.5% to $2.8 million in 2016, then tumbled by 81.56% to $514000.0 in 2017, then surged by 563.23% to $3.4 million in 2018.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $3.4 million, $514000.0, and -$339000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Integer Holdings | 4.26 Bn | 4.24 Bn | 112.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2018 | 3.41 Mn |
| Dec 29, 2017 | 514,000.00 |
| Sep 29, 2017 | -339,000.00 |
| Jun 30, 2017 | 318,000.00 |
| Mar 31, 2017 | 1.75 Mn |
| Dec 30, 2016 | 2.79 Mn |
| Sep 30, 2016 | 571,000.00 |
| Jul 1, 2016 | -1.25 Mn |
| Apr 1, 2016 | 367,000.00 |
| Jan 1, 2016 | -6,000.00 |
| Oct 2, 2015 | 689,000.00 |
| Jul 3, 2015 | -89,000.00 |
| Apr 3, 2015 | -600,000.00 |
| Oct 3, 2014 | -49,000.00 |
| Jul 4, 2014 | 86,000.00 |
| Apr 4, 2014 | 77,000.00 |
| Jan 3, 2014 | -17,000.00 |
| Sep 27, 2013 | -403,000.00 |
| Jun 28, 2013 | -231,000.00 |
| Mar 29, 2013 | 269,000.00 |